Clinical outcomes and prognostic indicators in parotid gland carcinomas: a single-center experience

Creative Commons License

Eroğlu E., Pamuk A. E., Bilen Y. E., Kuşcu O.

ACTA OTO-LARYNGOLOGICA, cilt.1, sa.1, ss.1-7, 2025 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 1 Sayı: 1
  • Basım Tarihi: 2025
  • Doi Numarası: 10.1080/00016489.2025.2490294
  • Dergi Adı: ACTA OTO-LARYNGOLOGICA
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, International Bibliography of Social Sciences, Biotechnology Research Abstracts, CAB Abstracts, CINAHL, EMBASE, Linguistics & Language Behavior Abstracts, Veterinary Science Database
  • Sayfa Sayıları: ss.1-7
  • Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
  • Hacettepe Üniversitesi Adresli: Evet

Özet

Background 

Parotid gland cancers (PGC) are a heterogeneous group with different histological types and grades. This difference has implications for patient management and adjuvant treatment decisions.

Objective 

This study aims to determine the poor prognostic factors affecting local control and survival in PGC.

Materials and methods 

A retrospective review of 42 patients treated for malignant parotid masses between January 2008 and December 2023. Risk factors analyzed included sex, age, histological grade, tumor size, stage, nodal involvement, perineural invasion (PNI), surgical margins, and additional treatments.

Results 

Of the 42 patients, 47.6% were male, and the median age was 44 years. The 5-year local relapse-free survival (LRFS) was 69.7%. Positive surgical margins significantly associated with lower LRFS rate (p = .007). The 5-year disease-specific survival (DSS) was 83.9%, with surgical margin and T stage being significant prognostic factors (0.044 and 0.031, respectively). Advanced T stage was associated with a higher rate of preoperative facial nerve dysfunction (p = .004).

Conclusions and significance 

This study underscores the critical role of comprehensive diagnostic and individualized surgical strategies in the treatment of parotid gland malignancies.